[
  {
    "ts": null,
    "headline": "Should Value Investors Buy Cardinal Health (CAH) Stock?",
    "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
    "url": "https://finnhub.io/api/news?id=3f153f53eca5b09f950d2491cfe73014a4901fc5de2ec39ba50d05f40a50cf04",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765377603,
      "headline": "Should Value Investors Buy Cardinal Health (CAH) Stock?",
      "id": 137750680,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
      "url": "https://finnhub.io/api/news?id=3f153f53eca5b09f950d2491cfe73014a4901fc5de2ec39ba50d05f40a50cf04"
    }
  },
  {
    "ts": null,
    "headline": "Are Medical Stocks Lagging  Aurinia Pharmaceuticals (AUPH) This Year?",
    "summary": "Here is how Aurinia Pharmaceuticals (AUPH) and Cardinal Health (CAH) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=23b3e246741550304a23a66f249daed848df7c01c54d090796c1db27feeb53c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765377603,
      "headline": "Are Medical Stocks Lagging  Aurinia Pharmaceuticals (AUPH) This Year?",
      "id": 137750679,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Here is how Aurinia Pharmaceuticals (AUPH) and Cardinal Health (CAH) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=23b3e246741550304a23a66f249daed848df7c01c54d090796c1db27feeb53c0"
    }
  },
  {
    "ts": null,
    "headline": "Is Cardinal Health Stock Outperforming the Nasdaq?",
    "summary": "Cardinal Health has outperformed the broader Nasdaq index over the past year. Moreover, Wall Street analysts remain strongly optimistic about its prospects.",
    "url": "https://finnhub.io/api/news?id=3d2e58e0accbcd667435790c909eccf0a324658644681d3b12cbe833665b5893",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765370993,
      "headline": "Is Cardinal Health Stock Outperforming the Nasdaq?",
      "id": 137750681,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal Health has outperformed the broader Nasdaq index over the past year. Moreover, Wall Street analysts remain strongly optimistic about its prospects.",
      "url": "https://finnhub.io/api/news?id=3d2e58e0accbcd667435790c909eccf0a324658644681d3b12cbe833665b5893"
    }
  },
  {
    "ts": null,
    "headline": "Barclays Initiates Coverage of Cardinal Health (CAH) with Overweight Recommendation",
    "summary": "Barclays Initiates Coverage of Cardinal Health (CAH) with Overweight Recommendation",
    "url": "https://finnhub.io/api/news?id=22f3d6e4f447ea086f7147c7353d00c83c95757ca0cf1f5705551ed60868bc1f",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765325024,
      "headline": "Barclays Initiates Coverage of Cardinal Health (CAH) with Overweight Recommendation",
      "id": 137744227,
      "image": "",
      "related": "CAH",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=22f3d6e4f447ea086f7147c7353d00c83c95757ca0cf1f5705551ed60868bc1f"
    }
  }
]